Skip to main content
Dogwood Therapeutics, Inc. logo

Dogwood Therapeutics, Inc. — Investor Relations & Filings

Ticker · DWTX ISIN · US92829J2033 US Professional, scientific and technical activities
Filings indexed 299 across all filing types
Latest filing 2026-04-27 Annual Report
Country US United States of America
Listing US DWTX

About Dogwood Therapeutics, Inc.

https://dwtx.com/

Dogwood Therapeutics, Inc. is a development-stage biotechnology company that focuses on advancing novel therapeutics for pain and neuropathy. The company's pipeline is centered on developing treatments for conditions such as moderate-to-severe chemotherapy-induced neuropathic pain, cancer pain, and other pain- and fatigue-related disorders. A key area of its research involves the development of novel sodium channel blockers, including its candidate Halneuron.

Recent filings

Filing Released Lang Actions
ARS - Dogwood Therapeutics, Inc. (0001818844) (Filer)
Annual Report
2026-04-27 English
DEF 14A - Dogwood Therapeutics, Inc. (0001818844) (Filer)
Proxy Solicitation & Information Statement
2026-04-27 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2026-02-13 English
8-K
Regulatory Filings
2026-01-20 English
FORM S-3
Registration Form
2026-01-15 English
8-K
Regulatory Filings
2026-01-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.